- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06469918
The Co-Op @ HeartWorks
October 2, 2025 updated by: HeartWorks, Inc.
This protocol is a research study involving human subjects diagnosed with Congenital Heart Defects/Disease (CHD).
The Co-Op @ HeartWorks is a cooperative between the research platform at HeartWorks and members of the CHD community.
Individuals choosing to participate will be referred to as 'members' of the co-op.
This study aims to create a database of members medical journey data to inform future clinical innovation and design of clinical trials which address the needs of the members.
The knowledge generated from this study will help advance the care of CHD patients through the deliberate action of The Co-Op @ HeartWorks members.
Unlike a traditional disease registry, the members of The Co-Op @ HeartWorks will actively inform and contribute to the future studies affecting their health.
Study Overview
Status
Recruiting
Conditions
Study Type
Observational
Enrollment (Estimated)
500
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Adam Armstrong
- Phone Number: (507) 577-1764
- Email: adam@webuildhearts.org
Study Locations
-
-
Minnesota
-
Rochester, Minnesota, United States, 55901
- Recruiting
- HeartWorks, Inc.
-
Contact:
- Clint Hagen, M.S.
- Phone Number: (507) 577-1764
- Email: clint@webuildhearts.org
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
Human subjects with congenital heart disease
Description
Inclusion Criteria:
- Adult with a congenital heart defects/disease
- Caregiver of a minor with a congenital heart defect/disease
- Authorized family member of a now deceased person with congenital heart defect/disease
Exclusion Criteria:
- Not having a congenital heart defect/disease
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Registry of individuals with CHD to plan and recruit for future interventional trials in Congenital Heart Defects/Disease
Time Frame: 25 years
|
25 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 24, 2024
Primary Completion (Estimated)
January 1, 2050
Study Completion (Estimated)
January 1, 2050
Study Registration Dates
First Submitted
June 14, 2024
First Submitted That Met QC Criteria
June 17, 2024
First Posted (Actual)
June 24, 2024
Study Record Updates
Last Update Posted (Estimated)
October 7, 2025
Last Update Submitted That Met QC Criteria
October 2, 2025
Last Verified
October 1, 2025
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Co-Op 001
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- ICF
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Congenital Heart Disease
-
IRCCS Azienda Ospedaliero-Universitaria di BolognaRecruitingAdult Congenital Heart Disease | Congenital Heart Disease (CHD) | Pediatric Congenital Heart Disease | Heart Transplant PatientsItaly
-
Seoul National University HospitalUniversity of SeoulNot yet recruitingCongenital Heart Disease in Children | Congenital Heart Disease (CHD) | Complex Congenital Heart DiseaseKorea, Republic of
-
University of UlsterBelfast Health and Social Care TrustCompletedCongenital Heart Disease | Congenital Heart Defect | Adult Congenital Heart DiseaseUnited Kingdom
-
China National Center for Cardiovascular DiseasesPeking University; Shandong University; Guangxi Medical University; Wenzhou Medical... and other collaboratorsActive, not recruitingStructural Heart Disease | Congenital Heart Disease (CHD)China
-
The Children's Hospital of Zhejiang University...Beijing Children's Hospital; Children's Hospital of Nanjing Medical UniversityNot yet recruitingCongenital Heart Disease in Children | Congenital Heart Disease (CHD)China
-
Martin SchweigerUniversity Children's Hospital, ZurichRecruitingFontan Physiology | Congenital Heart Disease in Children | Congenital Heart SurgerySwitzerland
-
Children's Hospital Medical Center, CincinnatiNational Heart, Lung, and Blood Institute (NHLBI)CompletedHeart Disease CongenitalUnited States
-
University Hospital, BordeauxNot yet recruitingCHD - Congenital Heart DiseaseFrance
-
Leiden University Medical CenterRecruitingAdult Congenital Heart DiseaseNetherlands
-
Cairo UniversityNot yet recruiting